CR7761A - Preparacion de liberacion controlada - Google Patents
Preparacion de liberacion controladaInfo
- Publication number
- CR7761A CR7761A CR7761A CR7761A CR7761A CR 7761 A CR7761 A CR 7761A CR 7761 A CR7761 A CR 7761A CR 7761 A CR7761 A CR 7761A CR 7761 A CR7761 A CR 7761A
- Authority
- CR
- Costa Rica
- Prior art keywords
- active ingredient
- controlled
- controlled release
- granule
- release preparation
- Prior art date
Links
- 239000003405 delayed action preparation Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 4
- 239000004503 fine granule Substances 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- 239000011247 coating layer Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee una preparacion de liberacion controlada en la cual la liberacion del ingrediente activo esta controlada, la cua libera un ingrediente activo durante un periodo prolongado de tiempo permaneciendo o migrando lentamente por el tracto gastrointestinal, mediante el encapsulamiento de una tableta, granulo o granulo fino en los cuales la liberacion del ingrediente activo esta controlada y un prolimero formador de geles. Dicha tableta, granulo o granulo fino presenta una capa de recubrimiento de liberacion controlada formada sobre una particula central que tiene un ingrediente activo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002301876 | 2002-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7761A true CR7761A (es) | 2005-06-09 |
Family
ID=35719193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7761A CR7761A (es) | 2002-10-16 | 2005-03-18 | Preparacion de liberacion controlada |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1713897B (es) |
| AR (1) | AR103296A2 (es) |
| CR (1) | CR7761A (es) |
| ZA (1) | ZA200502318B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0818286A2 (pt) * | 2007-10-12 | 2020-08-11 | Takeda Pharmaceuticals North America, Inc. | métodos de tratamento de distúrbios gastrointestinais independente da ingestão de alimento. |
| SMT201700346T1 (it) * | 2008-11-13 | 2017-09-07 | Nogra Pharma Ltd | Composizioni antisenso e metodi per la loro preparazione e loro uso |
| EP2501383A4 (en) * | 2009-11-20 | 2013-06-26 | Handa Pharmaceuticals Llc | ORAL FORMULATION FOR DEXLANDSOPRAZOLE |
| WO2011159745A1 (en) * | 2010-06-16 | 2011-12-22 | Takeda Pharmaceuticals North America, Inc. | Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors |
| CN116440094A (zh) * | 2022-01-06 | 2023-07-18 | 山东新时代药业有限公司 | 一种兰索拉唑缓释片剂及其制备方法 |
-
2003
- 2003-10-15 CN CN200380103935.2A patent/CN1713897B/zh not_active Expired - Lifetime
- 2003-10-15 ZA ZA200502318A patent/ZA200502318B/en unknown
-
2005
- 2005-03-18 CR CR7761A patent/CR7761A/es not_active Application Discontinuation
-
2015
- 2015-12-28 AR ARP150104311A patent/AR103296A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1713897B (zh) | 2012-07-04 |
| ZA200502318B (en) | 2006-11-29 |
| AR103296A2 (es) | 2017-05-03 |
| CN1713897A (zh) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR10284A (es) | Preparacion de liberacion controlada.(divisional exp. 7761) | |
| DK1578406T3 (da) | Farmaceutisk sammensætning med modificeret frigivelse | |
| JP2005501039A (ja) | 可変放出割合を持つ薬剤制御放出システム | |
| CY1112582T1 (el) | Διαδερμικη χορηγηση φεντανυλης | |
| DE60335557D1 (de) | Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum | |
| WO2006049942A3 (en) | Drug coated medical device with nucleating agents | |
| DOP2001000229A (es) | Forma de dosificación de fármaco activada por hidrogel | |
| WO2006015299A3 (en) | Multi-reservoir device for transdermal drug delivery and sensing | |
| ES2166769T3 (es) | Comprimido farmaceutico de liberacion controlada que presenta forma lenticular. | |
| AR061860A1 (es) | Prepracion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado y metodo para su fabricacion | |
| DE60307299D1 (de) | Enzymabhängige therapeutische wundverbände | |
| TW200735421A (en) | LED semiconductor body and use of an LED semiconductor body | |
| ATE428407T1 (de) | Oralen arzneiform mit oeffnungen in der äusseren hülle | |
| CR7761A (es) | Preparacion de liberacion controlada | |
| ATE519510T1 (de) | Antithrombogene und antirestenotische vaskuläre medizinprodukte | |
| ITRM20050103A1 (it) | Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi. | |
| AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
| UY26861A1 (es) | Composición de eletriptan en forma de partículas | |
| WO2006023644A3 (en) | Transdermal drug delivery device with translucent protective film | |
| HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
| WO2004109813A3 (de) | Lumineszenzdiode | |
| UY39790A (es) | Formulaciones de apremilast | |
| MX2022005321A (es) | Dispositivos medicos anticonceptivos. | |
| ITRM20010365A1 (it) | Dispositivo a sigaretta per la somministrazione per via aerea di sostanze medicinali e non. | |
| ITRM20040043A1 (it) | Della cura della tossicodipendenza con l'efeboclisi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |